{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T05:42:21Z","timestamp":1757310141183,"version":"3.40.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T00:00:00Z","timestamp":1703808000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T00:00:00Z","timestamp":1703808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100007316","name":"Division of Cancer Prevention, National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA016672"],"award-info":[{"award-number":["P30CA016672"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007314","name":"Duncan Family Institute for Cancer Prevention and Risk Assessment","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007314","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Betty B. Marcus Chair in Cancer Prevention"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Surviv"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s11764-023-01526-7","type":"journal-article","created":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T23:01:48Z","timestamp":1703890908000},"page":"1010-1018","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prevalence, reasons for use, perceived benefits, and awareness of health risks of cannabis use among cancer survivors \u2013 implications for policy and interventions"],"prefix":"10.1007","volume":"19","author":[{"given":"Ikponmwosa","family":"Osaghae","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onyema Greg","family":"Chido-Amajuoyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Talluri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Shete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,29]]},"reference":[{"issue":"1","key":"1526_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7\u201333. https:\/\/doi.org\/10.3322\/caac.21708.","journal-title":"CA Cancer J Clin"},{"issue":"22","key":"1526_CR2","doi-asserted-by":"publisher","first-page":"4488","DOI":"10.1002\/cncr.30879","volume":"123","author":"SA Pergam","year":"2017","unstructured":"Pergam SA, Woodfield MC, Lee CM, et al. Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational use. Cancer. 2017;123(22):4488\u201397. https:\/\/doi.org\/10.1002\/cncr.30879.","journal-title":"Cancer."},{"issue":"9","key":"1526_CR3","doi-asserted-by":"publisher","first-page":"7491","DOI":"10.1007\/s00520-022-07170-8","volume":"30","author":"NJ Raghunathan","year":"2022","unstructured":"Raghunathan NJ, Brens J, Vemuri S, Li QS, Mao JJ, Korenstein D. In the weeds: A retrospective study of patient interest in and experience with cannabis at a cancer center. Support Care Cancer. 2022;30(9):7491\u20137. https:\/\/doi.org\/10.1007\/s00520-022-07170-8.","journal-title":"Support Care Cancer."},{"key":"1526_CR4","unstructured":"National Institute of Health. Cannabis (marijuana) and cannabinoids: What you need to know. National Center for Complementary and Integrative Health Web site. https:\/\/www.nccih.nih.gov\/health\/cannabis-marijuana-and-cannabinoids-what-you-need-to-know. Updated 2019. Accessed 24 May 2023."},{"key":"1526_CR5","unstructured":"National Conference of State Legislatures. State medical cannabis laws. https:\/\/www.ncsl.org\/health\/state-medical-cannabis-laws. Updated 2022. Accessed 30 Jan 2023."},{"issue":"24","key":"1526_CR6","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1001\/jama.2015.6358","volume":"313","author":"PF Whiting","year":"2015","unstructured":"Whiting PF, Wolff RF, Deshpande S, et al. Cannabinoids for medical use: A systematic review and meta-analysis. JAMA. 2015;313(24):2456\u201373. https:\/\/doi.org\/10.1001\/jama.2015.6358.","journal-title":"JAMA."},{"key":"1526_CR7","doi-asserted-by":"publisher","first-page":"175883591986636","DOI":"10.1177\/1758835919866362","volume":"11","author":"AS Kleckner","year":"2019","unstructured":"Kleckner AS, Kleckner IR, Kamen CS, et al. Opportunities for cannabis in supportive care in cancer. Ther Adv Med Oncol. 2019;11:1758835919866362.","journal-title":"Ther Adv Med Oncol"},{"issue":"10","key":"1526_CR8","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1089\/jpm.2018.0528","volume":"22","author":"M Reblin","year":"2019","unstructured":"Reblin M, Sahebjam S, Peeri NC, Martinez YC, Thompson Z, Egan KM. Medical cannabis use in glioma patients treated at a comprehensive cancer center in Florida. J Palliat Med. 2019;22(10):122\u20131207. https:\/\/doi.org\/10.1089\/jpm.2018.0528.","journal-title":"J Palliat Med"},{"key":"1526_CR9","unstructured":"United States F. FDA regulation of cannabis and cannabis-derived products, including cannabidiol (CBD). U.S. Food and Drug Administration Web site. https:\/\/www.fda.gov\/news-events\/public-health-focus\/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd. Updated 2023. Accessed 24 May 2023."},{"issue":"5","key":"1526_CR10","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1001\/jamaoncol.2016.0155","volume":"2","author":"G Wilkie","year":"2016","unstructured":"Wilkie G, Sakr B, Rizack T. Medical marijuana use in oncology: A review. JAMA Oncol. 2016;2(5):670\u20135. https:\/\/doi.org\/10.1001\/jamaoncol.2016.0155.","journal-title":"JAMA Oncol"},{"issue":"17","key":"1526_CR11","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.3390\/molecules24173031","volume":"24","author":"D Namdar","year":"2019","unstructured":"Namdar D, Voet H, Ajjampura V, et al. Terpenoids and phytocannabinoids co-produced in cannabis sativa strains show specific interaction for cell cytotoxic activity. Molecules. 2019;24(17):3031. https:\/\/doi.org\/10.3390\/molecules24173031 (https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31438532).","journal-title":"Molecules."},{"issue":"1","key":"1526_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40463-019-0365-4","volume":"48","author":"H Zhang","year":"2019","unstructured":"Zhang H, Xie M, Levin M, et al. Survival outcomes of marijuana users in p16 positive oropharynx cancer patients. J Otolaryngol - Head Neck Surg. 2019;48(1):43. https:\/\/doi.org\/10.1186\/s40463-019-0365-4 (https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31477184).","journal-title":"J Otolaryngol - Head Neck Surg"},{"issue":"23","key":"1526_CR13","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMra1402309","volume":"370","author":"ND Volkow","year":"2014","unstructured":"Volkow ND, Baler RD, Compton WM, Weiss SRB. Adverse health effects of marijuana use. N Engl J Med. 2014;370(23):2219\u201327. https:\/\/doi.org\/10.1056\/NEJMra1402309.","journal-title":"N Engl J Med"},{"issue":"9","key":"1526_CR14","doi-asserted-by":"publisher","first-page":"e566","DOI":"10.1200\/JOP.18.00057","volume":"14","author":"CE Saadeh","year":"2018","unstructured":"Saadeh CE, Rustem DR. Medical marijuana use in a community cancer center. J Oncol Pract. 2018;14(9):e566\u201378. https:\/\/doi.org\/10.1200\/JOP.18.00057 (https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30205775).","journal-title":"J Oncol Pract"},{"issue":"5","key":"1526_CR15","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/fcp.12373","volume":"32","author":"R Bouqui\u00e9","year":"2018","unstructured":"Bouqui\u00e9 R, Deslandes G, Mazar\u00e9 H, et al. Cannabis and anticancer drugs: Societal usage and expected pharmacological interactions \u2013 a review. Fundam Clin Pharmacol. 2018;32(5):462\u201384. https:\/\/doi.org\/10.1111\/fcp.12373.","journal-title":"Fundam Clin Pharmacol"},{"issue":"16_suppl","key":"1526_CR16","doi-asserted-by":"publisher","first-page":"24114","DOI":"10.1200\/JCO.2022.40.16_suppl.e24114","volume":"40","author":"TM Brasky","year":"2022","unstructured":"Brasky TM, Newton AM, Conroy S, et al. Prevalence, symptom management, and reporting of cannabis use among invasive cancer patients. J Clin Oncol. 2022;40(16_suppl):24114. https:\/\/doi.org\/10.1200\/JCO.2022.40.16_suppl.e24114.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1526_CR17","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/cncr.33906","volume":"128","author":"MC Weiss","year":"2022","unstructured":"Weiss MC, Hibbs JE, Buckley ME, et al. A Coala-T-Cannabis survey study of breast cancer patients' use of cannabis before, during, and after treatment. Cancer. 2022;128(1):160\u20138. https:\/\/doi.org\/10.1002\/cncr.33906.","journal-title":"Cancer"},{"issue":"2","key":"1526_CR18","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3934\/publichealth.2020031","volume":"7","author":"I Jackson","year":"2020","unstructured":"Jackson I, Osaghae I, Ananaba N, Etuk A, Jackson N, Chido-Amajuoyi GO. Sources of health information among US cancer survivors: Results from the health information national trends survey (HINTS). AIMS Public Health. 2020;7(2):363\u201379. https:\/\/doi.org\/10.3934\/publichealth.2020031.","journal-title":"AIMS Public Health"},{"issue":"1","key":"1526_CR19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s11606-019-05335-6","volume":"35","author":"JH Ishida","year":"2020","unstructured":"Ishida JH, Zhang AJ, Steigerwald S, Cohen BE, Vali M, Keyhani S. Sources of information and beliefs about the health effects of marijuana. J Gen Intern Med. 2020;35(1):153\u20139. https:\/\/doi.org\/10.1007\/s11606-019-05335-6.","journal-title":"J Gen Intern Med."},{"issue":"2","key":"1526_CR20","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010.","journal-title":"J Biomed Inform"},{"issue":"1","key":"1526_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-034274","volume":"10","author":"S Keyhani","year":"2020","unstructured":"Keyhani S, Abraham A, Cohen B, et al. Development of a cannabis assessment tool (CAT-1) to measure current and lifetime marijuana use among older veterans. BMJ Open. 2020;10(1): e034274. https:\/\/doi.org\/10.1136\/bmjopen-2019-034274.","journal-title":"BMJ Open"},{"issue":"6","key":"1526_CR22","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1017\/S0033291714002463","volume":"45","author":"H L\u00f3pez-Pelayo","year":"2015","unstructured":"L\u00f3pez-Pelayo H, Batalla A, Balcells MM, Colom J, Gual A. Assessment of cannabis use disorders: A systematic review of screening and diagnostic instruments. Psychol Med. 2015;45(6):1121\u201333. https:\/\/doi.org\/10.1017\/S0033291714002463.","journal-title":"Psychol Med"},{"key":"1526_CR23","volume-title":"Applied survey data analysis. Second edition, first issued in","author":"S Heeringa","year":"2020","unstructured":"Heeringa S, West BT, Berglund PA. Applied survey data analysis. Second edition, first issued in. paperback. Boca Raton: CRC Press, Taylor & Francis Group; 2020.","edition":"paperback"},{"issue":"1","key":"1526_CR24","doi-asserted-by":"publisher","first-page":"E20","DOI":"10.5489\/cuaj.5911","volume":"14","author":"A Mousa","year":"2020","unstructured":"Mousa A, Petrovic M, Fleshner NE. Prevalence and predictors of cannabis use among men receiving androgen-deprivation therapy for advanced prostate cancer. Canadian Urological Association journal. 2020;14(1):E20\u20136. https:\/\/doi.org\/10.5489\/cuaj.5911 (https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31658007).","journal-title":"Canadian Urological Association journal."},{"issue":"9140","key":"1526_CR25","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/S0140-6736(98)05021-1","volume":"352","author":"W Hall","year":"1998","unstructured":"Hall W, Solowij N. Adverse effects of cannabis. Lancet (British edition). 1998;352(9140):1611\u20136. https:\/\/doi.org\/10.1016\/S0140-6736(98)05021-1.","journal-title":"Lancet (British edition)"},{"issue":"11","key":"1526_CR26","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.4187\/respcare.04846","volume":"61","author":"MP Martinasek","year":"2016","unstructured":"Martinasek MP, McGrogan JB, Maysonet A. A systematic review of the respiratory effects of inhalational marijuana. Respiratory Care. 2016;61(11):1543\u201351. https:\/\/doi.org\/10.4187\/respcare.04846 (https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27507173).","journal-title":"Respiratory Care."},{"issue":"21","key":"1526_CR27","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","volume":"376","author":"O Devinsky","year":"2017","unstructured":"Devinsky O, Cross JH, Laux L, et al. Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome. New England J Med. 2017;376(21):2011\u201320. https:\/\/doi.org\/10.1056\/NEJMoa1611618.","journal-title":"New England J Med"},{"issue":"7","key":"1526_CR28","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/nrc1887","volume":"6","author":"WD Figg","year":"2006","unstructured":"Figg WD, Scripture CD. Drug interactions in cancer therapy. Nat Rev Cancer. 2006;6(7):546\u201358. https:\/\/doi.org\/10.1038\/nrc1887.","journal-title":"Nat Rev Cancer"},{"key":"1526_CR29","doi-asserted-by":"publisher","unstructured":"Osaghae I, Chido-Amajuoyi OG, Khalifa BAA, Talluri R, Shete S (2023) Cannabis use among cancer survivors: use pattern, product type, and timing of use. Cancers 15(24):5822. https:\/\/doi.org\/10.3390\/cancers15245822","DOI":"10.3390\/cancers15245822"},{"key":"1526_CR30","unstructured":"State of Texas. Texas medical marijuana. https:\/\/www.texas.gov\/health-services\/texas-medical-marijuana\/. Updated 2023. Accessed Sept, 2023."},{"issue":"2","key":"1526_CR31","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/jamia\/ocac227","volume":"30","author":"C Richwine","year":"2023","unstructured":"Richwine C, Johnson C, Patel V. Disparities in patient portal access and the role of providers in encouraging access and use. J Am Med Inform Assoc: JAMIA. 2023;30(2):308\u201317. https:\/\/doi.org\/10.1093\/jamia\/ocac227 (https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/36451262).","journal-title":"J Am Med Inform Assoc: JAMIA."},{"issue":"3","key":"1526_CR32","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3122\/jabfm.2022.03.210486","volume":"35","author":"W Tuan","year":"2022","unstructured":"Tuan W, Mellott M, Arndt BG, Jones J, Simpson AN. Disparities in use of patient portals among adults in family medicine. J Am Board Fam Med. 2022;35(3):559\u201369. https:\/\/doi.org\/10.3122\/jabfm.2022.03.210486https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/35641056.","journal-title":"J Am Board Fam Med"}],"container-title":["Journal of Cancer Survivorship"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-023-01526-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11764-023-01526-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-023-01526-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T05:55:14Z","timestamp":1747288514000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11764-023-01526-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,29]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["1526"],"URL":"https:\/\/doi.org\/10.1007\/s11764-023-01526-7","relation":{},"ISSN":["1932-2259","1932-2267"],"issn-type":[{"type":"print","value":"1932-2259"},{"type":"electronic","value":"1932-2267"}],"subject":[],"published":{"date-parts":[[2023,12,29]]},"assertion":[{"value":"19 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no financial relationships relevant to this article to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial Disclosure"}},{"value":"The funders were not involved in the study design, analysis, interpretation of data, or manuscript writing.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Role of Funder\/Sponsor"}},{"value":"All authors have no conflict of interests relevant to this article to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}